Skip to main content
Explore URMC

URMC Logo

menu
URMC / Research / Research@URMC
Research at the New York Influenza Center of Excellence Continues with New NIH Grant

Research at the New York Influenza Center of Excellence Continues with New NIH Grant

Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines. 

Bird Flu is Back in China: URMC Testing Vaccine Candidate

Bird Flu is Back in China: URMC Testing Vaccine Candidate

Two new cases of H7N9 bird flu were reported in China in October. With funding from the National Institutes of Health, the University’s Vaccine Research Unit is testing a new vaccine candidate in case H7N9 makes its way to the U.S. 

Stomach Flu Vaccine Looks Good in Early Trial

Stomach Flu Vaccine Looks Good in Early Trial

A new vaccine for norovirus – the microbe behind most cases of what people commonly call stomach flu – protected patients against severe vomiting and diarrhea. URMC was one of five study sites that enrolled patients and tested the experimental vaccine. 

Researchers Call for Deeper Study of H7N9 Bird Flu Virus

Researchers Call for Deeper Study of H7N9 Bird Flu Virus

As part of the National Institutes of Health's Centers of Excellence in Influenza Research and Surveillance (CEIRS), URMC scientists John Treanor, M.D., and David Topham, Ph.D., join their peers in calling for more advanced research on the H7N9 bird flu virus that appeared in China earlier this year. In this video, they describe this research and why it’s important. 

12